Loading analysis...
Loading Truth Social...
Loading live updates...
—
S&P 500— —
Nasdaq— —
Dow Jones— —
载入时间机器…
Recent MRNA News Headlines
Latest news coverage for MRNA aggregated from WSJ, Bloomberg, The New York Times, Financial Times, and Google News. Real-time updates, free and ad-free.
- Moderna (MRNA) Is Up 18.4% After Cancer Vaccine Milestone And Nasdaq-100 Return Has The Bull Case Changed?
- Moderna (MRNA) Stock Looks Expensive Following Its 7x One Year Run
- Moderna (MRNA) Stock Sees Modest Fair Value Lift After Cancer Vaccine Analyst Revisions
- Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell?
- Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell?
- Why Moderna Stock Surged Today
- Why Moderna Stock Surged Today
- Moderna gains 14% to set fresh 52-week high (MRNA:NASDAQ)
- MRNA Stock Sets New 52-Week High As Nasdaq-100 Reentry Meets NIH Cancer-Vaccine Push
- Moderna stock hits 4-year high on planned national cancer vaccine effort
- Moderna Stock Hits New 52-Week High: What's Happening?
- Moderna Stock Skyrockets on Reports of U.S. Cancer Vaccine Initiative
- Moderna Stock Skyrockets on Reports of U.S. Cancer Vaccine Initiative
- A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally - Moderna (NASDAQ:MRNA), BioNTec
- Moderna options activity surges as Nasdaq-100 inclusion and melanoma data drive call buying
MRNA options: max pain, gamma exposure (GEX) & key levels · Search MRNA in the news archive · All tickers
Settings
Appearance
Card Style
Language
Notifications
Live View Style
Trump Truth Social
About
Version
2.6.1
Data Source
r/wallstreetbets
AI Engine
ChatGPT/Gemini/Claude
MCP Server
https://mcp.sellthenews.org/mcp
Contact Us
[email protected]